+91-8668442535

Pain Management Devices Market By Product (Electrostimulaiton Devices, Radiofrequency Ablation Devices, Infusion Pumps, Neurostimulation Devices), By Applications (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

This report provides an in-depth analysis and market insights into the global pain management devices market. The rising incidence of chronic pain, chronic debilitating diseases, and geriatric population pool play a vital role in the growing demand for pain management solutions worldwide. Furthermore, lower side effects from the use of devices than oral pain management solutions and surgeries also support the growth in demand for pain management devices. In addition, technical innovations are expected to serve as future opportunities for the pain management devices market growth.

For the purpose of this study, the global pain management devices market is segmented for product types, applications, and geography. In terms of product types, global pain management is categorized into electrostimulation devices, radiofrequency ablation devices, infusion pumps, and the neurostimulation devices market. 

These segments are further categorized as:

  • Electrostimulaiton Devices
  • Transcutaneous electrical nerve stimulation (TENS)
  • Neuromuscular electrical stimulation (NMES)
  • Others
  • Radiofrequency Ablation Devices
  • Infusion Pumps
  • Intrathecal analgesic pumps
  • External analgesic pumps
  • Neurostimulation Devices
  • Deep nerve stimulation
  • Sacral nerve stimulation
  • Vagus nerve stimulation
  • Spinal cord stimulation

Based on applications, this report studies the global pain management devices for applications in neuropathic pain, cancer pain, facial & migraine, musculoskeletal pain, and others. In addition, this study provides market analysis and forecast for the mentioned segments for the period 2014-2022 with the respective compounded annual growth rates (CAGRs) for the period 2016-2022.

In terms of geographical distribution, the global pain management devices market is studied for North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America markets. Among these, North America, Europe, and Asia-Pacific markets are further studied for top national markets as follows: North America (U.S. & Canada), Europe (U.K., Germany & Rest of Europe), and Asia-Pacific (Japan, China & Rest of Asia-Pacific). Each of the covered regions and country-level markets are studied in terms of their market size and forecast for the period 2014-2022 with their respective CAGRs for the period 2016-2022.

Along with the quantitative information sets, this report also includes qualitative market insights such as market dynamics: drivers, challenges and future market prospects. Competition assessment tools such as attractive investment proposition and fractal map analysis by key players are also provided in this study for investing in the competition in the global pain management devices market. This report concludes with a company profiles section that gives key information about major market players operating the pain management devices market.

The global pain management devices market is expected to be predominantly driven by the perpetual growth in the geriatric population pool that bear a high risk of chronic diseases, cancer, inflammatory conditions, arthritis, and others.

Neuropathic pain, cancer pain, facial & migraine, musculoskeletal pain, and others cumulatively make the major application areas for pain management devices. Neuropathic pain is a significant application for pain management devices; treatments such as spinal cord stimulation and deep nerve stimulation play a vital role in treating several neurological conditions. Customization of stimulation levels, respective to the severity of the conditions and long-term treatment efficacy, significantly contribute to the growth of this segment. Radiofrequency ablation devices have proven efficient in treating cancer pain by effectively terminating cancer cells by, this means reducing cancer pain.

Geographically, the global pain management devices market is cumulative to North America, Europe, Asia-Pacific, Middle East and Africa and Latin America.

Following the global medical devices market trends, North America is the largest market for pain management devices, followed by Europe. High prevalence of lifestyle diseases, cancer, osteoarthritis and the huge pool of high-risk geriatric population play a significant role in the dominance of North America and Europe pain management devices market. In addition, favorable reimbursement systems and better awareness among patients and caregivers contribute to the demand for pain management devices in the regions. Asia-Pacific and Latin America, with the rapid development of healthcare infrastructure, will become the fastest growing pain management devices market during the forecast period.

The detailed classification of the global pain management devices market is as follows:

  • North America (U.S. & Canada)
  • Europe (U.K., Germany and Rest of Europe)
  • Asia-Pacific (Japan, China and Rest of Asia-Pacific)
  • Middle East and Africa
  • Latin America

Frequently Aksed Questions

The market for Pain Management Devices is expected to reach USD XX Bn in 2022.

The Pain Management Devices market is expected to see significant CAGR growth over the coming years, at XX%.

The report is forecasted from 2016-2022

The base year of this report is 2015.

Baxter International, Inc., Boston Scientific Corp., Codman & Shurtleff, Inc., DJO Global, Inc., Hospira, Inc., Medtronic plc,St. Jude Medical, Smiths Medical, Stryker Corporation are some of the major players in the global market.

Choose License Type
Trusted By
Godaddy
Published Date:  Apr 2016
Category:  Medical Devices
Report ID:   57798
Report Format:   PDF
Pages:   140
Rating:    4.4 (60)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support